Skip to search formSkip to main contentSkip to account menu

stampidine

Known as: stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
The rationally designed novel anti-HIV drug candidate Stampidine exhibited (a) remarkable subnanomolar to low nanomolar in vitro… 
Review
2006
Review
2006
  • F. Uckun
  • 2006
  • Corpus ID: 29087706
Fig. 1: Global perspective of HIV crisis (2005) [2]. Since the first cases of Acquired Immune Deficiency Syndrome (AIDS) were… 
2005
2005
Summary The purpose of the present study was to compare the in vitro anti-HIV potency of stampidine (CAS 217178-62-6), a novel… 
2004
2004
Summary The in vitro activity profile of stampidine (CAS 217178-62-6, STAMP) was examined against clinical isolates of HIV-1. In… 
2003
2003
ABSTRACT Here we report the antiretroviral activity of the experimental nucleoside reverse transcriptase inhibitor (NRTI… 
2003
2003
Summary The in vivo toxicity and pharmacokinetics of stampidine (CAS 217178-62-6), an aryl phosphate derivative of stavudine (CAS… 
2003
2003
Abstract Stampidine [2′,3′-didehydro-2′,3′-dideoxythymidine 5′-[p-bromophenyl methoxyalaninyl phosphate], a prodrug of stavudine… 
2002
2002
We examined the pharmacokinetics and metabolism of the experimental nucleoside reverse transcriptase inhibitor compound… 
1998
1998
Three aryl phosphate derivatives of 2',3'-didehydro-2',3'-dideoxythymidine (d4T) were tested for their anti-human…